Pretoria, 08 November 2024 –The South African Health Products Regulatory Authority (SAHPRA) is concerned about the proliferation of falsified, compounded and substandard Glucagon-like Peptide (GLP-1)-containing products being made available to the public via websites, social media platforms and other informal channels. These pose a health...
As part of its pharmacovigilance programme, the South African Health Products Regulatory Authority (SAHPRA) recently partnered with the Independent Community Pharmacy Association (ICPA) to deliver an informative webinar on reporting adverse drug events and promoting the safe use of medicines to reduce the occurrence of...
Pretoria, 07 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) encourages members of the public to always report any suspected side effects they may experience from taking medicines, vaccines and/or using medical devices, to help make medicines safer for everyone. While humanity...
You are invited to the South African Health Product Regulatory Authority (SAHPRA) Complementary Medicines’ (CMs’) Hybrid Workshop. You have the option to attend the meeting either in-person or via our virtual platform. Areas of discussion on the agenda include: SAHPRA answers the 21 questions received...
The Medical Devices Unit of the South African Health Products Regulatory Authority (SAHPRA) is hosting a consultative meeting with Industry to communicate updates, compliance to legislative requirements, improvement of the application process and the overall client service and relations. Areas of discussion include: Payment of applicable...
Pretoria, 18 October 2024 - On the 25th and 26th of September 2024, the School of Physical and Chemical Sciences (SPCS) at North-West University’s Mafikeng Campus hosted a vibrant and educational “SPCS in Action” event. This two-day event gathered leading organisations in chemistry, biochemistry, and...
Pretoria, South Africa and Canberra, Australia, 07 October 2024 –The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. The MoU builds on the...
The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Ref: SAHPRA69092024 - Pharmaceutical Evaluations Management EOI closed on Friday, 26 April 2024. Appointments were made. Ref: SAHPRA20862023 - The EOI...
Pretoria, 16 September 2024 –The South African Health Products Regulatory Authority (SAHPRA) is proud to announce that it has received its first clean audit outcome from the Auditor-General of South Africa (AGSA) for the 2023/2024 financial year, following on a record of consistent unqualified audit...
The South African Health Products Regulatory Authority (SAHPRA) recently hosted the 3rd webinar in our Codeine Care Initiative (CCI) series, focusing on Patient Safety – Codeine’s Place in Pharmaceutical Care. Following our first module, which centred on holistic management for pain, cough, and colds, and the...
